Methotrexate
11
5
5
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
36%
4 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (11)
Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)
Role of Methotrexate in Ultrasound Proven Synovitis in Primary Knee OA
Efficacy and Safety of Resveratrol in Patients With Rheumatoid Arthritis.
Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial
Local vs Systemic Methotrexate in Management of Uterine Ectopic Pregnancy
Topical Methotrexate Microemulsion in the Treatment of Plaque Psoriasis
Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients
Dose Effect Relationship of MTX and IBD
Evaluation of the Impact of 3 Methods of Communication on the Adherence of Methotrexate in Patients With Rheumatoid Arthritis
2-week dc of MTX and Influenza Vaccination in RA
The Influence of Methotrexate on the Metabolism and Vascular Effects of Adenosine in Humans